Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment

This publication has 62 references indexed in Scilit:

• Production of a TEM-24 Plasmid-Mediated Extended-Spectrum β-Lactamase by a Clinical Isolate of Pseudomonas aeruginosa
  Antimicrobial Agents and Chemotherapy, 2000
• Interplay between the Efflux Pump and the Outer Membrane Permeability Barrier in Fluorescent Dye Accumulation in Pseudomonas aeruginosa
  Biochemical and Biophysical Research Communications, 1999
• Are we approaching the end of the antibiotic era?
  Current Opinion in Microbiology, 1998
• Cationic peptides: a new source of antibiotics
  Trends in Biotechnology, 1998
• Fluoroquinolones in the treatment of cystic fibrosis: A critical appraisal
  European Journal of Clinical Microbiology & Infectious Diseases, 1991
• Treatment of Pseudomonas lung infection in cystic fibrosis with piperacillin plus tobramycin versus ceftazidime monotherapy: Preliminary communication
  Pediatric Pulmonology, 1989
• Drug disposition in cystic fibrosis
  The Pediatric Infectious Disease Journal, 1987
• Antibiotic Pharmacokinetics in Cystic Fibrosis
  Clinical Pharmacokinetics, 1987
• Disposition of tobramycin in patients with cystic fibrosis: A prospective controlled study
  The Journal of Pediatrics, 1984
• THE PENETRATION OF ANTIBIOTICS THROUGH SODIUM ALGINATE AND THROUGH THE EXOPOLYSACCHARIDE OF A MUCOID STRAIN OF PSEUDOMONAS AERUGINOSA
  The Lancet, 1981